Skip to main content

Ziebell Mark R's Form 4 filing

Avid Bioservices, Inc. (CDMO) · filed Jun 30, 2023

Accession no.
0001683168-23-004598
Filed
Jun 30, 2023
Trade date
Jun 28-30, 2023
Filing delay
2 days
Rule 10b5-1 plan
Not checked

This filing lists 3 non-derivative transactions and 4 derivative transactions. Open-market sales total $47.5K. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Ziebell Mark RCIK 0001552642Officer (V. P., General Counsel)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Jun 28, 2023Common Stock, $0.001 par valueMOption exerciseAcquired+10,513–F1–50,632Direct
Jun 29, 2023Common Stock, $0.001 par valueSSaleDisposed−2,377$12.70F3−$30,187.948,255Direct
Jun 30, 2023Common Stock, $0.001 par valueSSaleDisposed−1,280$13.49−$17,267.246,975Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Jun 28, 2023Common StockMOption exerciseDisposed−3,789$0.00$051,421Direct
Jun 28, 2023Common StockDReturned to the companyDisposed−3,642$0.00$047,779Direct
Jun 28, 2023Common StockMOption exerciseDisposed−6,724$0.00$041,055Direct
Jun 28, 2023Common StockDReturned to the companyDisposed−6,725$0.00$034,330Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F1

Each performance stock unit ("PSU") represents the contingent right to receive, upon vesting, one share of the Issuer's Common Stock.

Referenced by the price of 1 transaction in Table I.

F3

Represents a weighted average sales price per share. These shares were sold at prices ranging from $12.70 to $12.80. The Reporting Person has provided to the Issuer, and hereby undertakes to provide the SEC staff or a security holder of the Issuer, upon request, information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)